157 related articles for article (PubMed ID: 34671128)
1. Menopausal hormone therapy and risk of oesophageal adenocarcinoma in a population-based cohort study.
Xie SH; Santoni G; Lagergren J
Br J Cancer; 2022 Jan; 126(1):129-133. PubMed ID: 34671128
[TBL] [Abstract][Full Text] [Related]
2. Menopausal hormone therapy and the risk of esophageal and gastric cancer.
Brusselaers N; Maret-Ouda J; Konings P; El-Serag HB; Lagergren J
Int J Cancer; 2017 Apr; 140(7):1693-1699. PubMed ID: 28006838
[TBL] [Abstract][Full Text] [Related]
3. Maintenance proton pump inhibition therapy and risk of oesophageal cancer.
Brusselaers N; Engstrand L; Lagergren J
Cancer Epidemiol; 2018 Apr; 53():172-177. PubMed ID: 29477057
[TBL] [Abstract][Full Text] [Related]
4. Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study.
Zheng J; Xie SH; Santoni G; Lagergren J
Br J Cancer; 2019 Nov; 121(10):877-882. PubMed ID: 31591459
[TBL] [Abstract][Full Text] [Related]
5. Use of anti-androgenic 5α-reductase inhibitors and risk of oesophageal and gastric cancer by histological type and anatomical sub-site.
Rabbani S; Santoni G; Lagergren J; Xie SH
Br J Cancer; 2022 Sep; 127(5):892-897. PubMed ID: 35715630
[TBL] [Abstract][Full Text] [Related]
6. Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?
Pandeya N; Webb PM; Sadeghi S; Green AC; Whiteman DC;
Gut; 2010 Jan; 59(1):31-8. PubMed ID: 19875392
[TBL] [Abstract][Full Text] [Related]
7. Menopausal hormone therapies and risk of colorectal cancer: a Swedish matched-cohort study.
Liu Q; Simin J; Debelius J; Fall K; Sadr-Azodi O; Engstrand L; Williams C; Brusselaers N
Aliment Pharmacol Ther; 2021 Jun; 53(11):1216-1225. PubMed ID: 33857339
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study.
Vaughan TL; Dong LM; Blount PL; Ayub K; Odze RD; Sanchez CA; Rabinovitch PS; Reid BJ
Lancet Oncol; 2005 Dec; 6(12):945-52. PubMed ID: 16321762
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden.
Chandanos E; Lindblad M; Jia C; Rubio CA; Ye W; Lagergren J
Br J Cancer; 2006 Jul; 95(1):118-22. PubMed ID: 16755290
[TBL] [Abstract][Full Text] [Related]
10. Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer.
Shore R; Yu J; Ye W; Lagergren J; Rutegård M; Akre O; Stattin P; Lindblad M
Sci Rep; 2021 Jun; 11(1):13486. PubMed ID: 34188067
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy is associated with gastro-oesophageal reflux disease: a retrospective cohort study.
Close H; Mason JM; Wilson D; Hungin AP
BMC Gastroenterol; 2012 May; 12():56. PubMed ID: 22642788
[TBL] [Abstract][Full Text] [Related]
12. NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.
Masclee GM; Coloma PM; Spaander MC; Kuipers EJ; Sturkenboom MC
BMJ Open; 2015 Jan; 5(1):e006640. PubMed ID: 25633286
[TBL] [Abstract][Full Text] [Related]
13. Association between menopausal hormone therapy use and mortality risk: a Swedish population-based matched cohort study.
Simin J; Khodir H; Fornes R; Tamimi RM; Brusselaers N
Acta Oncol; 2022 May; 61(5):632-640. PubMed ID: 35129052
[TBL] [Abstract][Full Text] [Related]
14. Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis.
Abnet CC; Freedman ND; Kamangar F; Leitzmann MF; Hollenbeck AR; Schatzkin A
Br J Cancer; 2009 Feb; 100(3):551-7. PubMed ID: 19156150
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy and oral contraceptives and risk of oesophageal adenocarcinoma: a systematic review and meta-analysis.
Lagergren K; Lagergren J; Brusselaers N
Int J Cancer; 2014 Nov; 135(9):2183-90. PubMed ID: 24676860
[TBL] [Abstract][Full Text] [Related]
16. Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer.
Macfarlane TV; Murchie P; Watson MC
Cancer Epidemiol; 2015 Dec; 39(6):1015-22. PubMed ID: 26590503
[TBL] [Abstract][Full Text] [Related]
17. Association of hormonal and reproductive factors with differentiated thyroid cancer risk in women: a pooled prospective cohort analysis.
O'Grady TJ; Rinaldi S; Michels KA; Adami HO; Buring JE; Chen Y; Clendenen TV; D'Aloisio A; DeHart JC; Franceschi S; Freedman ND; Gierach GL; Giles GG; Lacey JV; Lee IM; Liao LM; Linet MS; McCullough ML; Patel AV; Prizment A; Robien K; Sandler DP; Stolzenberg-Solomon R; Weiderpass E; White E; Wolk A; Zheng W; Berrington de Gonzalez A; Kitahara CM
Int J Epidemiol; 2024 Feb; 53(1):. PubMed ID: 38110618
[TBL] [Abstract][Full Text] [Related]
18. Aspirin or statin use in relation to survival after surgery for esophageal cancer: a population-based cohort study.
Holmberg D; Gottlieb-Vedi E; Hedberg J; Lindblad M; Mattsson F; Lagergren J
BMC Cancer; 2023 Apr; 23(1):375. PubMed ID: 37098462
[TBL] [Abstract][Full Text] [Related]
19. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis.
Cronin-Fenton DP; Murray LJ; Whiteman DC; Cardwell C; Webb PM; Jordan SJ; Corley DA; Sharp L; Lagergren J;
Eur J Cancer; 2010 Jul; 46(11):2067-76. PubMed ID: 20456945
[TBL] [Abstract][Full Text] [Related]
20. Menopausal hormone therapy and biliary tract cancer: a population-based matched cohort study in Sweden.
Kilander C; Lagergren J; Konings P; Sadr-Azodi O; Brusselaers N
Acta Oncol; 2019 Mar; 58(3):290-295. PubMed ID: 30656997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
